Literature DB >> 2160522

Metabolic and functional stimulation of lymphocytes and macrophages by an Escherichia coli extract (OM-89): in vitro studies.

T Van Pham1, B Kreis, S Corradin-Betz, J Bauer, J Mauël.   

Abstract

OM-89, a proteinaceous extract from Escherichia coli with very low endotoxin content, was tested for its capacity to stimulate in vitro cells involved in the immune response. OM-89 induced a marked proliferation of mouse spleen cells; E. coli lipopolysaccharide (LPS) at the same concentration as present in OM-89 was totally ineffective. Passage through nylon wool strongly decreased the OM-89-induced effect, suggesting that the responding lymphocytes were of the B lineage. Exposure of bone marrow-derived macrophages to OM-89 promoted glucose oxidation through the hexose monophosphate shunt pathway and the capacity to generate superoxide upon phorbol myristate acetate (PMA) stimulation. These effects were not blocked by polymyxin B, whereas this compound completely prevented induction of similar metabolic activation by E. coli lipopolysaccharide. In addition, OM-89 treatment induced marked PMA-dependent superoxide and hydrogen peroxide release by macrophages from the LPS low responder mouse strain C3H/HeJ. Incubation with recombinant murine interferon-gamma and OM-89, but not with either compound alone, led to functional activation, as shown by the killing of tumor target cells, and by the destruction of the intracellular parasite Leishmania enrietti by macrophages of both LPS-responsive and unresponsive mouse strains. These experiments indicate that OM-89 can stimulate metabolic and functional activities of lymphocytes and macrophages that are important for host defense.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2160522

Source DB:  PubMed          Journal:  J Biol Response Mod        ISSN: 0732-6580


  7 in total

1.  Follow-up with OM-8980 after a double-blind study of OM-8980 and auranofin in rheumatoid arthritis.

Authors:  T L Vischer
Journal:  Clin Rheumatol       Date:  1990-09       Impact factor: 2.980

2.  Immunostimulation in chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS): a one-year prospective, double-blind, placebo-controlled study.

Authors:  Florian M E Wagenlehner; Stefania Ballarini; Kurt G Naber
Journal:  World J Urol       Date:  2014-01-31       Impact factor: 4.226

3.  Anti-inflammatory effect of an Escherichia coli extract in a mouse model of lipopolysaccharide-induced cystitis.

Authors:  Seung-Ju Lee; Sae Woong Kim; Yong-Hyun Cho; Moon Soo Yoon
Journal:  World J Urol       Date:  2005-12-31       Impact factor: 4.226

4.  A prospective multi-center trial of Escherichia coli extract for the prophylactic treatment of patients with chronically recurrent cystitis.

Authors:  Kun Suk Kim; Ji-Yoon Kim; In Gab Jeong; Jae-Seung Paick; Hwancheol Son; Dae Jung Lim; Hong Bang Shim; Won Hee Park; Hee Chang Jung; Myung-Soo Choo
Journal:  J Korean Med Sci       Date:  2010-02-17       Impact factor: 2.153

Review 5.  Waging war against uropathogenic Escherichia coli: winning back the urinary tract.

Authors:  Kelsey E Sivick; Harry L T Mobley
Journal:  Infect Immun       Date:  2009-11-16       Impact factor: 3.441

Review 6.  Community-Acquired Urinary Tract Infection by Escherichia coli in the Era of Antibiotic Resistance.

Authors:  Dong Sup Lee; Seung-Ju Lee; Hyun-Sop Choe
Journal:  Biomed Res Int       Date:  2018-09-26       Impact factor: 3.411

Review 7.  Urinary Tract Infection in Parkinson's Disease.

Authors:  Elliot Hogg; Samuel Frank; Jillian Oft; Brian Benway; Mohammad Harun Rashid; Shouri Lahiri
Journal:  J Parkinsons Dis       Date:  2022       Impact factor: 5.520

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.